Fusion Pharmaceuticals Inc. Operating Expenses
Fusion Pharmaceuticals Inc. reported Operating Expenses of $35.86 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. operating expenses for the quarter ending 2024-03-31 was $35.86M, a 44.11% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating expenses for the quarter ending 2023-12-31 was $28.27M, a 15.14% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating expenses for the quarter ending 2023-09-30 was $21.39M, a 10.75% decline year-over-year.
- Fusion Pharmaceuticals Inc. operating expenses for the quarter ending 2023-06-30 was $26.75M, a 34.70% increase year-over-year.
- Fusion Pharmaceuticals Inc. operating expenses for fiscal 2023 was $101.30M, a 13.19% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. operating expenses for fiscal 2022 was $89.50M, a 7.24% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. operating expenses for fiscal 2021 was $83.45M, a 119.99% increase from fiscal 2020.
- Fusion Pharmaceuticals Inc. operating expenses for fiscal 2020 was $37.94M, a 108.21% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-03-31 | $35.86M 10-Q · filed 2024-05-07 | $64.14M derived: sum of 2 quarters · filed 2024-05-07 | $85.53M derived: sum of 3 quarters · filed 2024-05-07 | $112.28M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $28.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $49.67M derived: sum of 2 quarters · filed 2024-03-20 | $76.42M derived: sum of 3 quarters · filed 2024-03-20 | $101.30M 10-K · filed 2024-03-20 |
| 2023-09-30 | $21.39M 10-Q · filed 2023-11-07 | $48.14M derived: sum of 2 quarters · filed 2023-11-07 | $73.03M 10-Q · filed 2023-11-07 | $97.58M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $26.75M 10-Q · filed 2023-08-08 | $51.63M 10-Q · filed 2023-08-08 | $76.19M derived: sum of 3 quarters · filed 2024-05-07 | $100.16M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $24.88M 10-Q · filed 2024-05-07 | $49.44M derived: sum of 2 quarters · filed 2024-05-07 | $73.41M derived: sum of 3 quarters · filed 2024-05-07 | $93.27M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $24.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $48.53M derived: sum of 2 quarters · filed 2024-03-20 | $68.39M derived: sum of 3 quarters · filed 2024-03-20 | $89.50M 10-K · filed 2024-03-20 |
| 2022-09-30 | $23.97M 10-Q · filed 2023-11-07 | $43.83M derived: sum of 2 quarters · filed 2023-11-07 | $64.94M 10-Q · filed 2023-11-07 | $83.08M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $19.86M 10-Q · filed 2023-08-08 | $40.97M 10-Q · filed 2023-08-08 | $59.11M derived: sum of 3 quarters · filed 2023-08-08 | $78.95M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $21.11M 10-Q · filed 2023-05-11 | $39.26M derived: sum of 2 quarters · filed 2023-05-11 | $59.10M derived: sum of 3 quarters · filed 2023-05-11 | $86.89M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $18.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $37.99M derived: sum of 2 quarters · filed 2023-03-16 | $65.78M derived: sum of 3 quarters · filed 2023-03-16 | $83.45M 10-K · filed 2023-03-16 |
| 2021-09-30 | $19.84M 10-Q · filed 2022-11-08 | $47.63M derived: sum of 2 quarters · filed 2022-11-08 | $65.31M 10-Q · filed 2022-11-08 | $76.91M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $27.79M 10-Q · filed 2022-08-09 | $45.47M 10-Q · filed 2022-08-09 | $57.07M derived: sum of 3 quarters · filed 2022-08-09 | $67.39M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $17.68M 10-Q · filed 2022-05-10 | $29.28M derived: sum of 2 quarters · filed 2022-05-10 | $39.60M derived: sum of 3 quarters · filed 2022-05-10 | $46.91M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $11.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $21.92M derived: sum of 2 quarters · filed 2022-03-17 | $29.23M derived: sum of 3 quarters · filed 2022-03-17 | $37.94M 10-K · filed 2022-03-17 |
| 2020-09-30 | $10.32M 10-Q · filed 2021-11-09 | $17.63M derived: sum of 2 quarters · filed 2021-11-09 | $26.34M 10-Q · filed 2021-11-09 | $32.48M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $7.31M 10-Q · filed 2021-08-10 | $16.02M 10-Q · filed 2021-08-10 | $22.16M derived: sum of 3 quarters · filed 2021-08-10 | $26.32M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $8.70M 10-Q · filed 2021-05-11 | $14.84M derived: sum of 2 quarters · filed 2021-05-11 | $19.00M derived: sum of 3 quarters · filed 2021-05-11 | $22.91M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $6.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $10.30M derived: sum of 2 quarters · filed 2021-03-25 | $14.21M derived: sum of 3 quarters · filed 2021-03-25 | $18.22M 10-K · filed 2021-03-25 |
| 2019-09-30 | $4.16M 10-Q · filed 2020-11-10 | $8.07M derived: sum of 2 quarters · filed 2020-11-10 | $12.08M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $3.91M 10-Q · filed 2020-08-11 | $7.92M 10-Q · filed 2020-08-11 |